Eli Lilly and Company
Eli Lilly and Company is seeking a Scientific Director to lead pharmacokinetics and pharmacodynamics modeling for genetic medicine programs, including ASOs, siRNA, and gene therapies. The role involves developing quantitative modeling strategies to support drug discovery, translational research, and clinical development decisions. The position requires expertise in mechanistic PK/PD and PBPK modeling to optimize dosing and delivery of novel therapeutic modalities.
Headquarters
Indianapolis, Indiana, United States
Company Size
10001+ employees
Founded
1876
Eli Lilly and Company is a global biopharmaceutical company headquartered in Indianapolis, Indiana. It discovers, develops, manufactures and commercializes prescription medicines across therapeutic areas including diabetes, oncology, immunology, neuroscience and pain, and has a longstanding history in insulin and other major drug discoveries. Lilly invests heavily in research and clinical development and partners with biotech, academic institutions, and industry collaborators to advance biologics, small molecules, and precision medicines. The company operates global manufacturing and commercial networks and provides patient-support programs to improve access to its therapies.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Eli Lilly and Company.
Li Auto OTA Upgrade And Charging Use Test Investor Patience
1 week ago
Scientific Associate Director
MSD
Scientific Associate Director
Merck & Co., Inc.
Senior Principal Scientist, DMPK Translational PKPD Modeling
Neurocrine Biosciences
Associate Director
Novartis
Associate Director, PBPK-PD Translational Modeling, DMPK
GSK plc
Principal Scientist of Translational PK/PD Modeling
Regeneron Pharmaceuticals